# Investigation Into the Safety and Efficacy of ICG-Labeled Fluorescence Imaging Technology in Guiding the Resection of Bone and Soft Tissue Tumors

> **NCT06979115** · — · NOT_YET_RECRUITING · sponsor: **Guangdong Provincial People's Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Bone Neoplasms
- Soft Tissue Neoplasms

## Interventions

- **DRUG:** Indocyanine green (ICG)

## Key facts

- **NCT ID:** NCT06979115
- **Lead sponsor:** Guangdong Provincial People's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-05-25
- **Primary completion:** 2028-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06979115

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06979115, "Investigation Into the Safety and Efficacy of ICG-Labeled Fluorescence Imaging Technology in Guiding the Resection of Bone and Soft Tissue Tumors". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06979115. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*